EGM
HARP

Engineers Gate Manager’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Engineers Gate Manager’s Portfolio HARP Stock Details HARP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,160
Closed -$171K – 2362
2021
Q3 		$171K Buy
2,160
+338
+19% +$34K 0.01% 1468
2021
Q2 		$253K Buy
+1,822
New +$348K 0.02% 1262
2020
Q3 		– Sell
-1,002
Closed -$166K – 2062
2020
Q2 		$166K Buy
+1,002
New +$156K 0.01% 1490

Other funds holding HARP

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Engineers Gate Manager's HARP Position: Q4 2021 in Review

Engineers Gate Manager sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q4 2021, closing a stake of 2,160 shares — an estimated $171K sold.

Engineers Gate Manager first reported a position in HARP in Q2 2020 and held it in 3 quarters. The position peaked at $253K in Q2 2021. 84 funds tracked by Wall St. Rank hold HARP as of Q4 2021.

  • Engineers Gate Manager reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Engineers Gate Manager sold 2,160 Harpoon Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $171K.
  • Engineers Gate Manager first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q2 2020 and held it in 3 quarters.
  • Engineers Gate Manager's Harpoon Therapeutics, Inc. Common Stock position peaked at $253K in Q2 2021.
  • 84 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q4 2021.

Based on Engineers Gate Manager's 13F filing for Q4 2021, filed 14 Feb 2022.